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Abstract
Background: Infection with dengue viruses (DENV) causes a wide range of manifestations from asymptomatic infection to a
febrile illness called dengue fever (DF), to dengue hemorrhagic fever (DHF). The in vivo targets of DENV and the relation
between the viral burden in these cells and disease severity are not known.
Method: The levels of positive and negative strand viral RNA in peripheral blood monocytes, T/NK cells, and B cells and in
plasma of DF and DHF cases were measured by quantitative RT-PCR.
Results: Positive strand viral RNA was detected in monocytes, T/NK cells and B cells with the highest amounts found in B
cells. Viral RNA levels in CD14+ cells and plasma were significantly higher in DHF compared to DF, and in cases with a
secondary infection compared to those undergoing a primary infection. The distribution of viral RNA among cell
subpopulations was similar in DF and DHF cases. Small amounts of negative strand RNA were found in a few cases only. The
severity of plasma leakage correlated with viral RNA levels in plasma and in CD14+ cells.
Conclusions: B cells were the principal cells containing DENV RNA in peripheral blood, but overall there was little active
DENV RNA replication detectable in peripheral blood mononuclear cells (PBMC). Secondary infection and DHF were
associated with higher viral burden in PBMC populations, especially CD14+ monocytes, suggesting that viral infection of
these cells may be involved in disease pathogenesis.
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Introduction
Infection with dengue viruses (DENV) causes a wide range of
manifestations from asymptomatic infection to a febrile illness
called dengue fever (DF), to dengue hemorrhagic fever (DHF), a
viral hemorrhagic disease characterized by plasma leakage and
bleeding diathesis. [1] The mechanisms of severe dengue disease
are not completely elucidated. Both higher viral burden and
enhanced immune activation have been associated with severity.
[2] An important risk factor is a secondary DENV infection in a
host previously infected with DENV of another serotype. Cross-
reactive, non-neutralizing DENV-specific antibodies have been
shown to enhance viral attachment and uptake by immunoglob-
ulin receptor-bearing target cells, which may lead to higher viral
loads and more intense immune activation. [3,4]
The in vivo cellular targets of DENV remain to be completely
identified. Studies of human dengue cases have identified
macrophages and lymphoid cells as major targets of DENV as
supported by the presence of viral antigen and RNA. [5–9]
However, the relation of viral burden in various cell populations to
clinical severity and host immunological status has not been
examined. We measured DENV RNA in major cellular constit-
uents of peripheral blood mononuclear cells (PBMC) in dengue
cases and identified B cells as the principal cells harboring DENV
in both DF and DHF cases. Secondary infection and DHF were
associated with higher viral burden in selective populations of
PBMC.
Materials and Methods
Ethics Statement
Written informed consent was obtained from the parent or the
legal guardian of each study subject. The study was approved by
the Institutional Review Boards of the Thai Ministry of Public
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Health, the US Army Surgeon General’s Office and the University
of Massachusetts Medical School.
Clinical study design
The study design has been previously described. [10] Children 6
months to 18 years of age who presented with febrile illness
without an obvious source of infection within 72 hours after fever
onset at Queen Sirikit National Institute of Child Health were
enrolled and observed in hospital until one day after defervescence
and until clinically stable. Clinical and laboratory data including
hematocrit, platelet counts, liver enzyme (AST, ALT), and
albumin levels were collected daily. Plasma and PBMC samples
were collected daily during hospitalization and at a follow-up visit
during convalescence (four to six days after discharge). Plasma
were divided into aliquots and stored at 270uC. DENV infection
was confirmed by serology and by viral isolation and/or RT-PCR
of plasma. [11,12] Confirmed dengue cases were classified as
primary or secondary infection on the basis of IgM/IgG ELISA as
previously described. [12] Subjects were classified as DF or DHF
according to the World Health Organization criteria. [1] The day
of defervescence was defined as fever day 0, and the days before
(fever days 21, 22, etc.) and after (fever days +1, +2, etc.) were
numbered sequentially. All patients had a right lateral decubitus
chest radiograph performed one day after defervescence. The size
of the effusion was expressed as pleural effusion index (PEI) = the
vertical dimension of the fluid/the width of the hemithorax6100.
Hemoconcentration was defined as the percentage difference
between peak hematocrit reading during acute illness and the
baseline hematocrit reading at early convalescence.
Sample Selection
Samples were selected from archived specimens of clinically and
serologically characterized cases. Samples were selected to include
a representative subset of subjects from the parent study with
sufficient specimens available for isolation of PBMC subsets. To
provide data on changes over time in DENV RNA levels, we
limited our selection to cases with samples available from multiple
(at least 2) days during the febrile period. Samples from DF and
DHF cases, cases with primary and secondary DENV infection,
and viral serotypes were randomly selected. Twenty cases of DF
and fifteen cases of DHF were selected (Table 1). The clinical,
demographic, and virologic characteristics of the selected cases
and of all dengue cases enrolled during the same period are shown
(Table S1). Except the proportions of viral serotypes, there were
no statistically significant differences in the characteristics of the
DF and DHF cases selected for the study and all cases enrolled
during the same period. To compare the viral RNA levels in
PBMC subpopulations during primary and secondary infections,
we performed quantitative RT-PCR of cells collected on fever day
2 from 11 primary (4 cases as indicated in table 1 and an
additional 7 cases) and 15 secondary DENV infections. The
demographic and laboratory characteristics of these cases are
shown (Table S2).
PBMC isolation, storage, and fractionation
PBMC were isolated from whole blood by Ficoll-Hypaque
density gradient procedure. Cells were washed twice with RPMI
and resuspended in freezing media containing 20% fetal calf
serum, 10% DMSO in RPMI at 1–26106cells/ml. Cells were
gradually cooled at 270uC for 18 hours and then stored in the
vapor phase of liquid nitrogen for long term storage. One aliquot
containing 1–26106 cells was preserved in RNA preserving
solution and stored at 270uC. [13] To obtain subpopulations of
PBMC, cells were thawed and fractionated by sequential positive
selection using antibody-conjugated magnetic beads into CD14+,
CD2+, and CD20+ cells (Milteyni, Auburn, CA). The purity of the
fractionated cells was evaluated by immunostaining for cell surface
markers and flow cytometry.
Quantitative RT-PCR
Fractionated cells were lysed in Trizol solution (Life Technol-
ogies, Grand Island, NY) and RNA was extracted according the
manufacturer’s instructions. RNA was also extracted from 100 mL
of plasma. Reverse transcription and PCR for positive strand
DENV RNA were performed as described. [2] Primers used in
RT-PCR are shown in Table S3. Negative strand DENV RNA
was quantitated using tagged RT-PCR, a technique shown to
avoid false priming and thereby provide greater strand-specific
detection. [14] Briefly, a primer (TagF) which anneals to a
sequence common in all four dengue viruses and contains an
additional 59 exogenous sequence was used for reverse transcrip-
tion. The cDNA samples were purified with column to remove
excess primers. Quantitative PCR was performed with an
upstream primer containing only the tag sequence and serotype
specific downstream primers for DENV-1,- 2, and -3, and for
DENV-4. The amplified products of both the positive and
negative strand-derived cDNA were detected using the same set
of fluorogenic probes as both reactions amplified nearly identical
segments of the cDNA. The sample viral RNA concentrations
(copies/ml) were estimated based on a standard curve generated
with known concentrations of plasmid DNA containing dengue
viral sequence.
The number of cells in each PCR reaction was estimated by
quantitative RT-PCR for b2-microglobulin mRNA using primers-
B2M-forward (59TGCTCGCGCTACTCTCTCT39) and B2M-
reverse (59TCCATTCTCTGCTGGATGAC39) in RT-PCR con-
Table 1. Patient characteristics.
Clinical Diagnosis
DF DHF
Number of cases 20 15
Sex (M/F) 13/7 9/6
Age (mean(SD)) 8.7 (2.5) 9.3 (3.4)
Dengue serotypes
DENV1 5 4
DENV2 5 5
DENV3 6 3
DENV4 4 3
Serology
Primary infection 4 1
Secondary infection 16 14
Hemoconcentration (%)*(mean(SD)) 9.3 (7.8) 15.75 (12)
Lowest platelet counts* (mean(SD) 110350 (44909) 54066 (31605)
Peak AST (u/dl) (mean(SD) 107 (94) 160 (111)
Peak ALT (u/dl) (mean(SD) 57 (42) 95 (103)
Lowest albumin (g/dl) * (mean(SD) 4.15 (.49) 3.88 (.57)
Pleural effusion index (%) (mean
(range))
0 17.4 (0–56.6)
*Indicates statistically significant difference between DF and DHF (P,.05). Two
DHF cases met the definition of severe dengue according to the 2009 clinical
classification system.
doi:10.1371/journal.pone.0051335.t001
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taining Sybr green (Biorad, Hercules, CA). The cell numbers were
estimated based on a standard curve generated with known
numbers of PBMC. Cell-associated DENV RNA levels were
expressed as copies/million cells following the formula: copies/
million cells = ((viral RNA concentration (copies/ml)6PCR vol-
ume (ml))/cells per PCR)6106. All samples were assayed in
duplicate and the mean values were used for analyses. The ABI
gene detection system 7700 (Perkin-Elmer Applied Biosystems,
Carlsbad, CA) was used for PCR cycling amplification, data
collection, and analysis.
Statistical Analysis
Continuous variables were compared between groups using
Mann Whitney Test. Wilcoxon signed rank Test was used to
analyze differences in variables of individuals at different time
points or related variables within individual samples. Categorical
variables were compared between groups using Chi square test.
Correlations were analyzed using Spearman method. Multivariate
non-parametric test of independence was performed with Pillai’s
trace test. A P value,0.05 was considered to indicate statistical
significance. All tests were two sided.
Results
To assess the viral burden in plasma and various populations of
PBMC during DENV infection, we performed quantitative RT-
PCR for DENV RNA in 20 DF cases and 15 DHF cases (Table 1).
All of the subjects selected had specimens available from fever days
22 and 21. These cases represented approximately 10% of all
dengue cases enrolled during the same period and were not
significantly different in age, sex and serological status from the
whole cohort (Table S1). The notable difference is the relative
proportion of virus serotypes of the studied cases compared to that
of the whole cohort. This was due to our study design to include
roughly equal numbers of cases with each DENV serotype for this
analysis. The DF and DHF cases were not different in
demographic or serological characteristics. As expected, the mean
nadir platelet counts and albumin levels were lower in DHF cases
(Table 1). Two DHF cases with narrowed pulse pressure met the
definition of severe dengue according to the 2009 clinical
classification scheme. [15]
On the basis of previous studies indicating that viremia declines
at the time of defervescence [2] we selected plasma and PBMC
samples collected prior to defervescence for this analysis. PBMCs
were fractionated into CD14+ (monocytes), CD2+ (T and NK
cells), and CD20+ (B cells) cell fractions. The purity of each
fraction exceeded 90%, as assessed by flow cytometry. Quantita-
tive RT-PCR of fractionated cell RNA detected DENV RNA in
all fractions (Figure 1), with CD20+ cells harboring higher viral
RNA levels compared to CD14+ cells and CD2+ cells. The
distribution of DENV RNA among cell populations was similar in
DF and DHF. Plasma DENV RNA levels were significantly higher
in DHF cases compared to DF cases (p = .001) (Figure 1A). The
CD14+ cell fractions from DHF cases also contained higher
DENV RNA levels than those from DF cases (p = .01). Plasma
viral RNA levels declined significantly from fever day 22 to fever
day 21 in all cases (p = .001) (Figure 1B). The viral RNA in cell
fractions did not change significantly between these 2 time points)
(Figure 1 C, D, E). To examine the effects of host serological status
on cellular viral burden, we compared the levels of DENV RNA in
PBMC subpopulations of 11 primary and 15 secondary DENV
infections, all of whom had DF. As shown in figure 2, viral RNA
levels in CD14+ and CD2+ cell fractions were higher in patients
with secondary infection than those with primary infection. There
was no significant difference in plasma viral RNA levels between
primary and secondary infections.
To determine whether there was evidence of active DENV
replication in PBMC, we performed strand-specific quantitative
RT-PCR to detect negative strand DENV RNA using tagged RT-
Figure 1. Dengue virus in plasma and peripheral blood mononuclear cells. Comparisons of dengue viral (DENV) RNA levels in plasma and
PBMC subpopulations in DF and DHF cases two days prior to defervescence (fever day 22) (A). * indicates statistically significant differences in DENV
RNA levels between DF and DHF (P,.05). +indicates differences between DENV RNA levels in CD20+ cells compared to CD14+ and CD2+ cells
(P,.05). (B, C, D, E) Levels of DENV RNA levels in plasma (B), CD14+ (C), CD2+ (D) and CD20+ (E) cells on fever day 22 and fever day 21. Each line
represents individual cases: solid lines: DHF, dashed lines: DF.
doi:10.1371/journal.pone.0051335.g001
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PCR. [14] Experiments employing this technique to measure the
amount of positive and negative viral RNA in DENV-infected
C6/36 cells revealed that the negative strand RNA levels were 1–
2% of positive strand RNA (Table S4). No negative strand RNA
was detected in RNA extracted from uninfected cells or when the
Tag sequence primer was omitted from the PCR of DENV
infected cells.
We performed quantitative RT-PCR for both positive and
negative strand genomes using RNA samples extracted from
PBMC preserved in RNA preserving solution at the time of
collection (fever day 22). As shown in figure 3, we detected very
low copy numbers of negative strand DENV RNA in a few of
these PBMC samples, indicating that very little active viral
replication is detectable in PBMC.
We examined the correlations between viral RNA levels and
parameters of disease severity. The levels of viral RNA in plasma
and CD14+ cells on fever day-2, but not in CD2+ or CD20+ cells,
correlated with the size of pleural effusions, an indicator of the
severity of plasma leakage (Table 2). In agreement with this, nadir
albumin levels inversely correlated only with viral RNA levels in
plasma and CD14+ cells. Although the levels of viral RNA in
plasma correlated significantly with RNA levels in CD14+ cell
fraction (r2 = 0.474, P= .001), multivariate analysis showed that
these parameters independently correlated with pleural effusion
index (P= .001). Nadir platelet counts showed an inverse
correlation with viral RNA levels in CD2+ cells. Viral RNA levels
in plasma or cell fractions did not correlate with hemoconcentra-
tion or hepatic transaminase levels.
Discussion
Our results demonstrate that peripheral blood B cells, T cells,
and monocytes harbor DENV genomes during acute infection.
The DENV RNA content associated with each of these cell
populations was low (less than 1 copy/cell), however, indicating
that no more than a small minority of cells within each fraction
contains DENV in vivo. Consistent with this finding, we have been
unable to detect DENV infected peripheral blood cells by flow
cytometry (unpublished observation). Our results are in agreement
with a previous study demonstrating low viral detection and
recovery rate from PBMC. [16] This is in contrast to flow
cytometric studies demonstrating high frequencies of peripheral
blood cells, including B cells and monocytes, expressing DENV
antigens [7,8]. Although antibodies to DENV structural proteins
could detect cells that have taken up viral particles without
productive infection, one study using an antibody specific to the
DENV NS3 protein suggested that active viral replication was
occurring in ,10% of CD14+ cells. [8] However, the strikingly
high percentages of DENV-infected cells in peripheral blood
reported in these studies were not corroborated by a study
employing in situ hybridization. [6] Differences in study design
and populations may explain these disparate results; further studies
are needed to provide clarification.
We found that B cells harbored the highest viral RNA levels
among the cell types studied. This is consistent with other studies
identifying B cells as the major cell population in peripheral blood
that expressed DENV antigens and harbored infectious virus. [7,9]
In addition, an in situ hybridization study of spleen and lymph
nodes of fatal dengue cases revealed DENV RNA in what
appeared to be centroblasts in germinal centers, indicating the
presence of DENV in B cells in secondary lymphoid organs. [6]
Since circulating B cells are in transit from secondary lymphoid
tissues to bone marrow [17], it is possible that antigenic
stimulation in secondary lymphoid tissue leads to the expansion
of B cells expressing DENV-specific antibodies, which facilitate
DENV capture and entry into these cells. A recent study
demonstrating high frequencies of dengue-specific plasmablasts
in peripheral blood during an acute infection supports this notion.
[18] The detection of viral RNA in CD2+ cells was somewhat
unexpected. Although activated T cells have been shown to
support DENV replication in vitro [19], to our knowledge this is
the first documentation of DENV RNA in T/NK cells in clinical
samples.
Figure 2. DENV RNA levels in plasma and PBMC subpopula-
tions in primary and secondary infections. Plasma and PBMC cell
subpopulations of 11 primary and 15 secondary DENV infections, all of
whom had DF, were analyzed. * indicates statistically significant
differences in DENV RNA levels between primary and secondary
infection (P,.05). +indicates differences between DENV RNA levels in
CD20+ cells compared to CD14+ and CD2+ cells (P,.05).
doi:10.1371/journal.pone.0051335.g002
Figure 3. Positive and negative strand DENV RNA levels in
unfractionated PBMC. Quantitative PCR for positive and negative
strand viral RNA was performed with RNA extracted from unfraction-
ated PBMC collected on fever day-2 from subjects infected with DENV1
(A), DENV2 (B), DENV3 (C), or DENV4 (D). The range of the positive
strand DENV RNA was 0 to 6069 copies/million cells. Negative strand
DENV RNA was detected in 6 of 18 samples with detectable positive
strand RNA and the levels ranged from 5 to 35 copies/million cells.
doi:10.1371/journal.pone.0051335.g003
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High plasma viral load has been associated with increased
severity of dengue illness. [2] We have demonstrated in this study
that, during secondary infections, viral load in CD14+ cells is also
higher in DHF compared to DF. Conversely, secondary DENV
infection was also associated with higher viral RNA levels in
CD14+ and CD2+ cell fractions. The higher cell-associated
DENV RNA in secondary infection may be mediated by cross-
reactive antibodies that enhance viral capture and entry into
peripheral blood cells via Fc receptors. The relative abundance of
dengue-specific IgG and IgM antibodies and the expression of
various Fc receptors for IgG and IgM by different cells may
determine the cellular distribution of viral RNA during primary
and secondary infections. However, we did not observe differences
in the cellular distribution of viral RNA between primary and
secondary infections. It is possible that differences may exist
between subpopulations not delineated in this study such as
activated T and B cells.
Studies have demonstrated that monocytes, B cells, and
activated T cells can support DENV replication in vitro. [19,20]
However, a study employing in situ hybridization with sense
ribonucleotide probes failed to identify replicative intermediate of
DENV in human tissue samples. [6] Using a negative strand-
specific PCR technique, we found negative strand DENV RNA
only in a few PBMC samples and the levels were ,1% of the
positive strand DENV RNA levels in the same sample. This
suggests that viral replication is occurring in a minority of PBMC
that harbor viral RNA. Another study employing quantitative RT-
PCR reported up to 10,000 copies of negative strand DENV RNA
per million PBMC, which represented 1–5% of positive strand
DENV RNA genome copies and was interpreted to indicate active
DENV replication. [21] However, the amount of negative strand
DENV RNA detected in that study might have been overestimat-
ed, as a tagged primer technique was not used.
We observed a decline in plasma DENV RNA levels at the time
of defervescence as previously reported. [2] In contrast, no
contemporaneous decline in cell-associated virus was observed.
The sustained viral burden in PBMC might be relevant in dengue
pathogenesis since DENV-infected cells serve both as producers of
pro-inflammatory cytokines, including TNFa and IL-6 [20] and
also as antigen-presenting cells capable of inducing cytokine
production by DENV-specific T cells. We did not note any
association between the kinetics of cell-associated DENV RNA
and disease severity. Our study was limited to peripheral blood,
however, and may not fully reflect the kinetics of DENV RNA in
tissues.
Our study demonstrated several correlations between indicators
of disease severity and viral RNA levels in plasma or PBMC
populations. Interestingly, indicators of plasma leakage (pleural
effusion index and nadir albumin levels) showed statistically
significant associations only with viral RNA levels in plasma and
CD14+ cells. The selective correlation of plasma leakage with viral
RNA levels in CD14+ cells suggests that these cells may play an
important and direct role in this disease process. DENV-infected
monocytes/macrophages have been shown to produce proin-
flammatory cytokines with permeability-enhancing effects. [20,22]
Notably, there was a significant correlation (r2 = 0.474) between
viral RNA levels in plasma and in CD14+ cells. Therefore, the
relative contributions of virus in these two compartments to
plasma leakage could not be clearly delineated. It is also possible
that the viral RNA levels in these two compartments are
mechanistically related and both may contribute to plasma
leakage. Similar correlations were not observed between viral
RNA levels and hemoconcentration. However, hemoconcentra-
tion can be obscured by hemorrhage and fluid treatment, both of
which are more common in DHF cases. We also observed an
association between nadir platelet counts and CD2+ cell viral load.
CD2+ T cells including NK and T cells may be activated by virus-
antibody complexes and mediate antibody-dependent cytolysis
directed against platelet or platelet progenitors expressing viral
antigens on their surface.
Our findings are subject to several limitations. The number of
cells required for cell sorting and quantitative RT-PCR analysis
limited the number of cases that could be studied. However, the
clinical and demographic characteristics of the selected cases did
not significantly differ from those of the total dengue cases enrolled
during the same period, suggesting that we did not introduce any
bias by our selection. The paucity of DHF cases with a primary
infection precluded the analysis of a relation between clinical
severity and viral RNA levels in primary infections. The small
number of samples representing each viral serotype in this study
might have limited our ability to detect serotype-associated
differences in DENV RNA distribution among cell populations.
In addition, our assay method would not differentiate between
surface and intracellular virus, a distinction that may have
implications on cell signaling and cytokine responses. Studies
have shown that the interaction of virus-antibody complexes with
Fc receptors may induce the production of inhibitory cytokines,
such as IL-10. [23,24] On the other hand, DENV infection has
been shown to induce proinflammatory cytokines including
chemokines, TNF-a, and interferons. [20,22,25] Since archived
frozen cell samples were used in this study, our analysis might have
Table 2. Univariate correlations between indicators of disease severity and viral RNA levels in plasma and cell fractions collected
on fever day-2.
Source of viral RNA Correlations with indicators of disease severity (R (p value))
Pleural effusion
index
Nadir albumin
levels
Liver enzyme
(AST)
Liver enzyme
(ALT)
Hemo
concentration Nadir platelet counts
Plasma .532 (.002) 2.466 (.008) .015 (.934) .15 (.397) .103 (.562) 2.209 (.252)
CD14+ .477 (.008) 2.466 (.033) .115 (.543) .15 (.425) .259 (.166) 2.430 (.05)
CD2+ .29 (.114) 2.265 (.157) .175 (.346) .277 (.131) .237 (.199) 2.479 (.038)
CD20+ .353 (.098) 2.071 (.747) .185 (.399) .142 (.519) .223 (.307) 2333 (.141)
Correlations between viral RNA levels in plasma and cell fractions on fever day 22 and indicators of disease severity were analyzed by Spearman’s Rho test. Multivariate
non-parametric test of independence revealed that plasma viral RNA levels and viral RNA levels in CD14+ cell fraction independently correlated with pleural effusion
index (P = .001).
doi:10.1371/journal.pone.0051335.t002
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included only cells that survived cryopreservation but not cells that
might have undergone activation induced cell death particularly T
cells. Further studies that examine fresh samples from cases with
different viral serotypes and employ techniques that can differen-
tiate between viral infection and surface viral attachment will be
needed to answer these questions.
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